Trial Profile
A Phase I, Single- And Multiple-Dose, Relative Bioavailability and Pharmacokinetic Study of Encapsulated Mesalamine [mesalazine] Granules Administered Orally to Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Nov 2019
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Colorectal cancer; Microscopic colitis; Ulcerative colitis; Ulcerative proctitis
- Focus Pharmacokinetics
- Sponsors Bausch Health Companies; Salix Pharmaceuticals
- 25 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Mar 2008 New trial record.